We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
+12.47%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$2.13B
AUM Growth
+$203M
Cap. Flow
-$12.1M
Cap. Flow %
-0.57%
Top 10 Hldgs %
30.3%
Holding
2,428
New
30
Increased
109
Reduced
927
Closed
85

Sector Composition

Rank Sector Weight
1 Technology 24.26%
2 Financials 10.88%
3 Healthcare 10.85%
4 Consumer Discretionary 9.35%
5 Industrials 7.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ONIT
2151
Onity Group
ONIT
$327M
$11K ﹤0.01%
359
CMCL icon
2152
Caledonia Mining Corp
CMCL
$440M
$11K ﹤0.01%
904
RRGB icon
2153
Red Robin
RRGB
$186M
$10.9K ﹤0.01%
877
OMER icon
2154
Omeros
OMER
$1.27B
$10.9K ﹤0.01%
3,344
ALTI icon
2155
AlTi Global
ALTI
$464M
$10.9K ﹤0.01%
1,243
JANX icon
2156
Janux Therapeutics
JANX
$985M
$10.8K ﹤0.01%
1,004
LAW icon
2157
CS Disco
LAW
$297M
$10.7K ﹤0.01%
1,412
BWFG icon
2158
Bankwell Financial Group
BWFG
$542M
$10.7K ﹤0.01%
354
MLYS icon
2159
Mineralys Therapeutics
MLYS
$2.3B
$10.6K ﹤0.01%
1,238
+511
+70% +$4.01K
OVID icon
2160
Ovid Therapeutics
OVID
$513M
$10.6K ﹤0.01%
3,287
CNSL
2161
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
$10.6K ﹤0.01%
2,433
-1,605
-40% -$6.64K
INFU icon
2162
InfuSystem Holdings
INFU
$247M
$10.6K ﹤0.01%
1,003
IBEX icon
2163
IBEX
IBEX
$481M
$10.6K ﹤0.01%
555
ENTA icon
2164
Enanta Pharmaceuticals
ENTA
$396M
$10.5K ﹤0.01%
1,114
HRTX icon
2165
Heron Therapeutics
HRTX
$63M
$10.5K ﹤0.01%
6,161
NKSH icon
2166
National Bankshares
NKSH
$272M
$10.4K ﹤0.01%
323
SFIX
2167
Stitch Fix
SFIX
$492M
$10.4K ﹤0.01%
2,922
-1,658
-36% -$5.85K
STHO icon
2168
Star Holdings Shares of Beneficial Interest
STHO
$118M
$10.4K ﹤0.01%
695
-372
-35% -$4.64K
BCBP icon
2169
BCB Bancorp
BCBP
$163M
$10.3K ﹤0.01%
805
CDXS icon
2170
Codexis
CDXS
$180M
$10.3K ﹤0.01%
3,389
ATLO icon
2171
AMES National
ATLO
$284M
$10.3K ﹤0.01%
484
SAMG icon
2172
Silvercrest Asset Management
SAMG
$79.6M
$10.3K ﹤0.01%
607
GLUE icon
2173
Monte Rosa Therapeutics
GLUE
$1.35B
$10.3K ﹤0.01%
1,820
IHRT icon
2174
iHeartMedia
IHRT
$478M
$10.3K ﹤0.01%
3,847
-2,729
-41% -$6.9K
BPRN icon
2175
Princeton Bancorp
BPRN
$295M
$10.3K ﹤0.01%
286

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q4 2023 Portfolio in Review

As of Q4 2023, Metropolitan Life Insurance Company (MetLife) held 2,428 positions worth $2.13B, up 11% from $1.93B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Trading was light in Q4 2023: portfolio turnover was 4.7%. Metropolitan Life Insurance Company (MetLife) opened 30 new positions and exited 85, leaving the 2,428-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q4 2023 buy was iShares Broad USD Investment Grade Corporate Bond ETF: 578,568 shares worth $29.7M.
  • Metropolitan Life Insurance Company (MetLife) added most to iShares Core US Aggregate Bond ETF in Q4 2023, an estimated $38.1M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q4 2023 reduction was Apple, cutting an estimated $2.39M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Vanguard Total Bond Market in Q4 2023, selling an estimated $72.5M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 30% of its $2.13B portfolio in Q4 2023.
  • Metropolitan Life Insurance Company (MetLife) opened 30 new positions and closed 85 in Q4 2023.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value rose 11% quarter-over-quarter to $2.13B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2023, filed 14 Feb 2024.